Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis

BACKGROUND: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators significantly improve pulmonary function in patients with cystic fibrosis (CF) but the effect on hepatobiliary outcomes remains unknown. We hypothesized that CF patients on CFTR modulators would have a decreased incide...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsey, Mitchell L, Wellner, Michael R, Porter, Kyle, Kirkby, Stephen E, Li, Susan S, Lara, Luis F, Kelly, Sean G, Hanje, A James, Sobotka, Lindsay A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891668/
https://www.ncbi.nlm.nih.gov/pubmed/35317183
http://dx.doi.org/10.4254/wjh.v14.i2.411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891668/
https://www.ncbi.nlm.nih.gov/pubmed/35317183
http://dx.doi.org/10.4254/wjh.v14.i2.411

Ejemplares similares